---
title: "Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688131.SH.md"
symbol: "688131.SH"
name: "Shanghai Haoyuan Chemexpress Co., Ltd."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-19T19:34:44.576Z"
locales:
  - [en](https://longbridge.com/en/quote/688131.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688131.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688131.SH.md)
---

# Shanghai Haoyuan Chemexpress Co., Ltd. (688131.SH)

## Company Overview

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.chemexpress.com.cn](https://www.chemexpress.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: B (0.37)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 25 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 26.48% |  |
| Net Profit YoY | -0.79% |  |
| P/B Ratio | 4.89 |  |
| Dividend Ratio | 0.11% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 15227236837.10 |  |
| Revenue | 2996557824.74 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.97% | B |
| Profit Margin | 8.18% | B |
| Gross Margin | 52.43% | B |
| Revenue YoY | 26.48% | A |
| Net Profit YoY | -0.79% | C |
| Total Assets YoY | 13.58% | B |
| Net Assets YoY | 9.24% | B |
| Cash Flow Margin | 157.72% | B |
| OCF YoY | 26.48% | A |
| Turnover | 0.49 | C |
| Gearing Ratio | 49.95% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Shanghai Haoyuan Chemexpress Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "26.48%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-0.79%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.89",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.11%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "15227236837.10",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "2996557824.74",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.97%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "8.18%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "52.43%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "26.48%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-0.79%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "13.58%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "9.24%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "157.72%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "26.48%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.49",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "49.95%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 61.19 | 12/25 | 59.34 | 52.00 | 46.59 |
| PB | 4.82 | 23/25 | 5.42 | 5.02 | 4.19 |
| PS (TTM) | 5.00 | 8/25 | 6.11 | 5.56 | 4.88 |
| Dividend Yield | 0.11% | 17/25 | 0.35% | 0.32% | 0.27% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-14T16:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 50% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 70.76 |
| Highest Target | 94.00 |
| Lowest Target | 94.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/688131.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/688131.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/688131.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/688131.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**